Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference
Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference
MINNEAPOLIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024.
明尼阿波利斯，2024年11月06日(GLOBE NEWSWIRE) -- inspire medical systems, Inc. (纽交所: INSP) (Inspire)，一家专注于开发和商业化创新、微创解决方案，用于治疗阻塞性睡眠呼吸暂停症患者的医疗科技公司，今天宣布其管理团队将于2024年11月20日(周三)在Jefferies伦敦医疗保健大会上发表演讲。
Inspire is scheduled to present at 11:00 a.m. Eastern Time. The presentation will be accessible via a live webcast here.
Inspire计划在美国东部时间上午11:00进行演讲。演示将通过此处的现场网络广播进行访问。
Webcast replays of the presentations will be available for two weeks following the presentations in the Event Archive section of Inspire's Investor website at .
演示的网络广播重播将在演示结束后的两周内通过Inspire投资者网站的活动存档部分提供。
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology of its kind that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
关于inspire 医疗系统
Inspire是一家专注于开发和商业化创新、微创解决方案，用于治疗阻塞性睡眠呼吸暂停症患者的医疗科技公司。Inspire的专有Inspire疗法是首款并且唯一一款获得FDA、EU MDR和PDMA批准的神经刺激技术，为中重度阻塞性睡眠呼吸暂停提供安全有效的治疗方案。
For additional information about Inspire, please visit .
更多关于inspire的信息，请访问。
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
投资者和媒体联系人
Ezgi Yagci
投资者关系副总裁
ezgiyagci@inspiresleep.com
617-549-2443